Titlebook: Cell Culture Engineering and Technology; In appreciation to P Ralf P?rtner Book 2021 The Editor(s) (if applicable) and The Author(s), under

Autopsy

書目名稱Cell Culture Engineering and Technology影響因子(影響力)




書目名稱Cell Culture Engineering and Technology影響因子(影響力)學(xué)科排名




書目名稱Cell Culture Engineering and Technology網(wǎng)絡(luò)公開度




書目名稱Cell Culture Engineering and Technology網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Cell Culture Engineering and Technology被引頻次




書目名稱Cell Culture Engineering and Technology被引頻次學(xué)科排名




書目名稱Cell Culture Engineering and Technology年度引用




書目名稱Cell Culture Engineering and Technology年度引用學(xué)科排名




書目名稱Cell Culture Engineering and Technology讀者反饋




書目名稱Cell Culture Engineering and Technology讀者反饋學(xué)科排名

Suggestions

Remote Control of Mammalian Therapeutic Designer Cellsar of medicine. Controlling and fine-tuning the behaviour of engineered cells is therefore becoming increasingly important. In the quest for the best-in-class genetic control modalities, traceless physical cues such as light, temperature, mechanical force, magnetic fields, and electrical pulses have

自然環(huán)境

PAGAN

疲勞

手段

Monoclonal Antibody Glycoengineering for Biopharmaceutical Quality Assurancecribed for the treatment of several types of cancer and autoimmune disorders. Glycosylation is considered a critical quality attribute of mAbs because it is essential to the safety, pharmacokinetics, and pharmacodynamics of these life-saving biopharmaceuticals. High degrees of glycosylation variabil

手段

大吃大喝

Manufacturing Human Pluripotent Stem Cells and Differentiated Progenitorsdies have thus far demonstrated the maintenance of cells in static culture plates, which are difficult to scale-up to industrial manufacturing due to the vast quantities of cells required for therapy. Bioreactors have become the most promising alternative for large-scale production and studies have

Fillet,Filet

Biomanufacturing of Mesenchymal Stromal Cells for Therapeutic Applicationsed by degenerative diseases, or indirectly through secretion of trophic or immunomodulatory factors. However, it is estimated that 10.–10. MSCs are needed for a single dose. This, combined with the fact that MSC populations are heterogenous, presents a number of manufacturing challenges. Selection o

nepotism